Strata Critical Medical (SRTA) Accounts Payables (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Accounts Payables data on file, last reported at $20.0 million in Q1 2026.

• Quarterly Accounts Payables rose 89.96% year-over-year to $20.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.0 million (up 89.96% YoY) and the FY2025 annual result came in at $19.1 million, up 107.61% from the prior year.
• Accounts Payables grew to $20.0 million in Q1 2026 per SRTA's latest filing, from $19.1 million in the prior quarter.
• Across five years, Accounts Payables topped out at $27.2 million in Q3 2025 and bottomed at $7.6 million in Q2 2022.
• The 5-year median for Accounts Payables is $14.9 million (2023), against an average of $15.1 million.
• The widest annual swing landed in 2022, when Accounts Payables jumped 589.67%; it then plunged 61.36% in 2024.
• Tracing SRTA's Accounts Payables over 5 years: stood at $16.5 million in 2022, then jumped by 44.29% to $23.9 million in 2023, then sank by 61.36% to $9.2 million in 2024, then soared by 107.61% to $19.1 million in 2025, then advanced by 4.25% to $20.0 million in 2026.
• Per Business Quant, the three latest SRTA Accounts Payables figures stand at $20.0 million (Q1 2026), $19.1 million (Q4 2025), and $27.2 million (Q3 2025).

Peer Comparison